Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, 79110 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79110 Freiburg im Breisgau, Germany.
Cells. 2021 Oct 28;10(11):2923. doi: 10.3390/cells10112923.
Cardiac electrophysiological disorders, in particular arrhythmias, are a key cause of morbidity and mortality throughout the world. There are two basic requirements for arrhythmogenesis: an underlying substrate and a trigger. Altered conduction velocity (CV) provides a key substrate for arrhythmogenesis, with slowed CV increasing the probability of re-entrant arrhythmias by reducing the length scale over which re-entry can occur. In this review, we examine methods to measure cardiac CV in vivo and ex vivo, discuss underlying determinants of CV, and address how pathological variations alter CV, potentially increasing arrhythmogenic risk. Finally, we will highlight future directions both for methodologies to measure CV and for possible treatments to restore normal CV.
心脏电生理紊乱,特别是心律失常,是全世界发病率和死亡率的一个主要原因。心律失常发生有两个基本要求:潜在的底物和触发因素。传导速度的改变(CV)为心律失常的发生提供了一个关键的底物,减慢 CV 通过减少折返发生的长度尺度来增加折返性心律失常的可能性。在这篇综述中,我们检查了体内和体外测量心脏 CV 的方法,讨论了 CV 的潜在决定因素,并探讨了病理变化如何改变 CV,从而可能增加心律失常的风险。最后,我们将重点介绍用于测量 CV 的方法学和可能恢复正常 CV 的治疗方法的未来方向。